Collaboration. Acceleration. Results.
Myelin Repair Foundation Home Page

Newsroom

Here is a listing of our current media-related activities and resources along with links to our archive:

Recent Media Coverage

San Francisco Business Times, How a white powder couldn't pass U.S. Customs but could save MS patients, May 1, 2015
Case Western Reserve University - The Daily, Drugs stimulate body’s stem cells to replace the brain cells lost in multiple sclerosis, April 20, 2015
ScienceLife: The University of Chicago, Blood pressure drug protects against symptoms of multiple sclerosis in animal models, March 13, 2015
NeurologyNow, Getting at the Root of MS, December 2014 / January 2015
The New Exploratory Urge, May 2014
Life Science Leader, Life Science Partnerships With Patient Foundations: The Best Practices, June 2, 2014
Pharmaceutical Executive, Pushing the Boundaries of MS Research: The Myelin Repair Foundation, February 28, 2014
Multiple Sclerosis Discovery Forum, MS Research Roundup: February 12, 2014
View entire articles and press coverage archive.

- Back to top -

Recent Press Releases

The Myelin Repair Foundation and National Institutes of Health Initiate Clinical Studies of Guanabenz for Treatment of Multiple Sclerosis (April 30, 2015)
Blood pressure drug protects against symptoms of multiple sclerosis in animal models (March 13, 2015)
Conrad N. Hilton Foundation Grants Myelin Repair Foundation $1.35 Million Matching Grant to Support Myelin Repair Research (November 24, 2014)
Myelin Repair Foundation Announces Long-Term European Partnership with Hertie Foundation (August 11, 2014)
Bionure Inc.’s MS Drug Candidate Shows Positive Results for Myelin Repair in Cell Culture Assay (May 27, 2014)
View entire press release archive.

- Back to top -

Background Information

Myelin Repair Foundation Overview (PDF)
The Myelin Repair Foundation's Translational Medicine Platform (PDF)
View entire background and whitepaper archive.

- Back to top -

Video Interviews and Talks

Hear Myelin Repair Foundation CEO Scott Johnson talk about how we're accelerating research for myelin repair therapeutic drugs for multiple sclerosis.

Mendel's Pod:
When Drug Discovery Gets Personal

Watch When Drug Discovery Gets Personal

12Gurus 2012:
Where are the Cures?

The Myelin Repair Foundation is a 501(c)(3), non-profit, tax-exempt charitable organization.

Photos by: Babuljak Photography

Copyright © 2002 - Myelin Repair Foundation. All rights reserved. Send email to Myelin Repair Foundation.

The content on this webpage is offered for informational purposes only. The information is not provided for the purpose of giving medical advice or recommending specific treatment options for any medical condition or health problem. You should never use the content of the webpage or any other information located on the website as a substitute for a thorough and complete discussion with your doctor about a medical condition or health problem you may have, and you should not rely on the materials in the websites when choosing a treatment plan or evaluating any other medical advice regarding any disease or medical condition. The Myelin Repair Foundation strongly urges you to consult one or more licensed physicians who are trained to diagnose and treat the symptoms of MS and other neurological diseases. The Myelin Repair Foundation makes no warranties whatsoever, express or implied, regarding the accuracy, completeness, timeliness, or usefulness of any information contained or referenced on the website. Health-related information and technology change frequently and therefore information contained in the website may be outdated, incomplete or incorrect. The Myelin Repair Foundation does not assume any risk whatsoever for your use of the information contained on the website and your use of the website and the materials contained herein is at your own risk.